NASDAQ:BIS - ProShares UltraShort Nasdaq Biotechnology Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$20.23 -0.32 (-1.56 %)
(As of 11/16/2018 04:00 PM ET)
Previous Close$20.5501
Today's Range$20.07 - $20.86
52-Week Range$15.38 - $24.48
Volume72,595 shs
Average Volume60,833 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.09%
BetaN/A
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Receive BIS News and Ratings via Email

Sign-up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIS
Inception Date4/7/2010
Fund ManagerMichael Neches, Tarak Dave
Phone+1-240-4976400

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology TR USD
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$31.54 million
Average Daily Volume$113,768.00
Discount/Premium-0.68%

ETF Expenses

Management Fee0.75%
Other Expenses0.36%
Total Expenses1.11%
Fee Waiver-0.16%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Currency Exposure of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Sector Exposure of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Industry Exposure of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Frequently Asked Questions

What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?

ProShares UltraShort Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIS."

How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology announced a special dividend on Thursday, September 27th. Stockholders of record on Thursday, September 27th will be paid a dividend of $0.0181 per share on Wednesday, October 3rd. The ex-dividend date of this dividend is Wednesday, September 26th. View ProShares UltraShort Nasdaq Biotechnology's Dividend History.

Has ProShares UltraShort Nasdaq Biotechnology been receiving favorable news coverage?

News coverage about BIS stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ProShares UltraShort Nasdaq Biotechnology earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the next few days.

Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders?

ProShares UltraShort Nasdaq Biotechnology's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Wealthsource Partners LLC (4.66%), Virtu Financial LLC (2.43%) and Tower Research Capital LLC TRC (1.10%). View Institutional Ownership Trends for ProShares UltraShort Nasdaq Biotechnology.

Which institutional investors are selling ProShares UltraShort Nasdaq Biotechnology stock?

BIS stock was sold by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC . View Insider Buying and Selling for ProShares UltraShort Nasdaq Biotechnology.

Which institutional investors are buying ProShares UltraShort Nasdaq Biotechnology stock?

BIS stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC and Wealthsource Partners LLC. View Insider Buying and Selling for ProShares UltraShort Nasdaq Biotechnology.

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProShares UltraShort Nasdaq Biotechnology's stock price today?

One share of BIS stock can currently be purchased for approximately $20.23.

What is ProShares UltraShort Nasdaq Biotechnology's official website?

The official website for ProShares UltraShort Nasdaq Biotechnology is http://www.proshares.com/.

How can I contact ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400.


MarketBeat Community Rating for ProShares UltraShort Nasdaq Biotechnology (NASDAQ BIS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about ProShares UltraShort Nasdaq Biotechnology and other stocks. Vote "Outperform" if you believe BIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2018 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel